A daily stock analysis based on stock market today
  • Daily Roll
  • YouTube
  • Podcast
  • Investor Hubs
    • Starter Investors Hub
    • Dividend Seekers Hub
    • The Risk Hub
    • COVID-19 Investing Hub
  • Sign Up

Why Were Marijuana Stocks Up Today? Are TLRY and CGC Worth a Buy?

7/28/2021

 

KEY POINTS

  • The stock market ended the day mixed after the Fed released remarks from its monetary policy meeting.
  • Tilray (TLRY) earnings boost marijuana stocks and give a positive outlook for the industry.
  • Canopy Growth (CGC) refocuses on profitability and free cash flow while the outlook on American legalization remains fuzzy.

OVERALL MARKET

The stock market ended the day mixed after the Fed released remarks from its monetary policy meeting.
Picture
Today’s market indices ended the day mixed.

The DOW Jones was down, while the S&P 500 finished in the red by a hair. The NASDAQ managed to stay in the green. This comes after a statement by the Federal Reserve confirming that the economy has shown great improvement. Chair Jerome Powell emphasized that the Fed is not planning on pulling back its favorable money policies until the nation was sustainably back on track. Some investors are growing impatient that the Fed is not addressing the rising inflation as a challenge and keeps its policies. That's most likely what contributed to the market's mixed results. 

GET THE DAILY MARKET RECAP

Did you know you can get your Daily Market recap report on YouTube, listen to it on our Podcast, or get it in your inbox?

Watch it, 
Listen to it, 
Or, read it.  
 
Sign up for a free Stock Card account to get the report in your mailbox every day.

GIVE STOCK CARD A TRY!

WHAT'S UP WITH MJ?

Tilray (TLRY) earnings boost marijuana stocks and give a positive outlook for the industry.
Today, several cannabis stocks showed up on the winners' list. I typed in "cannabis" in the search bar, and the cannabis (marijuana) collection on Stock Card is registering all green. Marijuana stocks have declined all year since the retail-fueled trading frenzy earlier in 2021 with other meme stocks. Why are cannabis stocks suddenly rocketing? 

The industry has struggled with COVID shutdowns and closing dispensaries, where customers are more likely to spend money on more expensive products than shopping online. This was Tilray’s (TLRY) response to slightly underwhelming revenue during its earnings call yesterday. The stock is up over 25% today for its positive results. Tilray showed a 27% increase in revenue year-over-year, with a 55% growth in cannabis revenue specifically. The company operates mainly in the Canadian market but has branched out to Europe with its merger this May with Aphria. Aphria was operating in the same industry but making most of its revenue from its branch in the German medical marijuana market. 

Despite COVID challenges, the positive outlook by Tilray boosted several marijuana stocks higher today. Growth is on the horizon for companies on both sides of the border. In the U.S., statistics show that nationwide cannabis sales increased 67% in 2020, while 12% of Americans are active marijuana users. With more states legalizing it by the day, the market is ever-growing. Not a surprise to see investors are digging marijuana stocks once again.

REVISITING AN MJ STOCK

Canopy Growth (CGC) refocuses on profitability and free cash flow while the outlook on American legalization remains fuzzy.
Yesterday a fellow Stock Cardian, Robert Milling, asked me whether it's time to buy CGC now that the price is lower than what I paid for it. I own Canopy Growth Corp (CGC) in my portfolio and have kept that as my foot in the industry's door. I also picked it because it is one of the well-funded companies in that sector. Robert made me go back and see what's going on with CGC.

Canopy Growth Corp (CGC) is operating in Canada like Tilray and holds licenses to distribute medical marijuana products in over twelve other countries. The company has been rapidly expanding in the Canadian market, but it is still losing money each year. Profitability is one reason the company has been cutting some celebrity partnerships. If you take a look at the company’s Stock Card, you’ll find that it has a great outlook on industry growth, and its sales revenue has been on a promising upward trend for a while. My strategy to keep a foot in the door still applies as CGC continues to focus on growth and profitability. 

The risk I'm taking with CGC is still quite high. While the industry has seen plenty of growth in states and countries where marijuana has been legalized, there’s still quite a ways to go.Accordingly to Wikipedia, only two countries, Canada and Uruguay, have fully legalized commercial activities nationwide. More countries have legalized recreational or medical use, but full commercialization is still just beginning. In the U.S., a new bill has been introduced to the Senate for the federal legalization of marijuana.  The time it will take to reach that point is anybody’s guess. Marijuana investors need to be patient and master their emotions during market volatility. 

The steep losses this year do present a buying opportunity if you want to take a long position on a marijuana stock but prepare to hold through some major volatility over the coming years from the U.S. market. CGC or Tilray either can be a good one to consider, you may also take a look at marijuana-focused ETFs such as MJ, although I haven’t yet looked at the ETFs in detail. 

FREEDOM PORTFOLIO

Check out Paul Essen’s portfolio, our featured investor and partner of the week.
​Okay, let's wrap up by stopping by Paul Essen's portfolio. You can find it on Stock Card's Stock Picks page. Paul and his Freedom portfolio are the Featured investor and partner of the week. He is one of the best long-term investors I like to follow on Stock Card. He and I had a chat about his investment strategy earlier this week. I’ll leave a link to that conversation in the show notes. Drop by Pauls' Freedom portfolio and follow him to get notified of his buys and sells. 

WANT TO RECIEVE THIS DAILY STOCK MARKET RECAP IN YOUR MAILBOX?

Sign up for a free account on Stock Card's website to get the daily market recap reports in your inbox:
GIVE STOCK CARD A TRY!

Comments are closed.

    RSS Feed


    Archives

    December 2022
    September 2022
    July 2022
    February 2022
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    February 2021
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    January 2020
    October 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017

    Categories

    All
    Battle
    Education
    ETF Investing
    How To Invest
    New Podcast Episode
    New Portfolio
    Portfolio Update
    Starter 2020
    Stock Card VIP Pick
    Stock Lists
    The Daily Hype
    Update
    Watchlist Worthy
    Winners And Losers

© 2017 StockCard.io. All Rights Reserved.
​​
Disclaimer: StockCard.io is not, neither operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on StockCard.io and Stock Card Weekly represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The Stock Card team may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall StockCard.io be liable to any subscriber, visitor, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on StockCard.io, or relating to the use of, or inability to use, StockCard.io or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
  • Daily Roll
  • YouTube
  • Podcast
  • Investor Hubs
    • Starter Investors Hub
    • Dividend Seekers Hub
    • The Risk Hub
    • COVID-19 Investing Hub
  • Sign Up